CMI 7-8/14

30.07.2014 • Topics

Materials Science and Engineering

30.07.2014 • Topics

Photochemistry and Photophysics:

30.07.2014 • Topics

Handbook of Spectroscopy

30.07.2014 • Topics

The Chemical Bond:

30.07.2014 • Topics • Technology

German Chemical Companies are doing Good Business

30.07.2014 • Topics • Strategy

Sales in the Chemical Industry

A study themed "Sales excellence - Boost your sales power" conducted by Simon-Kucher & Partners together with CHEManager International reveals that chemical companies focus their sales activities primarily on the goals of either boosting profits or acquiring new customers.

30.07.2014 • Topics • Strategy

Multichannel Excellence: The Competitive Factor for Pharma

30.07.2014 • Topics • Chemistry

A Sustainable Partnership

30.07.2014 • Topics • Strategy

Distributor-Supplier Relationship in the Chemical Industry

30.07.2014 • Topics • Chemistry

Chlor-Alkali Strives to Stay Competitive

30.07.2014 • Topics • Technology

Digging in the Digital Mountain

29.07.2014 • Topics • Technology

A Growing Base for Business

29.07.2014 • Topics • Technology

Gases for Emerging Markets from Saxony-Anhalt

29.07.2014 • Topics • Strategy

German Chemical Producers See TTIP as a “Political Chance”

29.07.2014 • Topics • Strategy

Dyneon Prepares for the Future

29.07.2014 • Topics • Strategy

China Tackles Its Major Economic Issues

29.07.2014 • Topics • Strategy

Potential In Eastern Europe

Top-Feature

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Concept Heidelberg

ECA Foundation Aims to Become Largest Pharma Association for GMP/GDP Compliance

Nova-Institut GmbH

Advanced Recycling Conference 2025: New Paths to the Circular Economy

MOC – Event Center Messe München

A successful concept on course for expansion — maintenance Munich 2025

CHEManager International c/o Wiley-VCH GmbH

20 Years of CHEManager International

Interview

Stability in Motion

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Chemical Market Reporter

Wacker Chemie

Thomson Reuters

Managm. Consult. Chemicals

IMG - Investment and Marketing Corporation Saxony-Anhalt

Camelot Management Consultants AG

Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

Dyneon GmbH